| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_245379a7c26fb28a3fff381486c03320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81e5e5b8bf9385af8644bb09b9c75df0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0306 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 |
| filingDate |
2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93b05873aa96fc1e3be023ea33632d6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b72aa0132de10f65f63dc63a5dab7aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f5ab20f1f0b10007f52e573b6dd54d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fa2baf0aa72ddf93c2a37664c2c58d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9163ec26d0b139d960d539b487841b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd6362dcf92405def7ba0d8e7c8d3a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5674947bec18eae9fd3e1d41ce9c0c42 |
| publicationDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2465346-A2 |
| titleOfInvention |
Humanised psoriasis model |
| abstract |
The invention relates to a novel humanised animal psoriasis model. Said model is generated by means of the grafting of humanised skin equivalents in the animal, the injection of T lymphocytes and cytokines involved in the generation of the disease in humans, and the implementation of the tape-stripping technique for damaging said grafted equivalents. Said model can be used to study the disease and to identify and evaluate the efficiency of the compounds in controlling said disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2918166-A1 |
| priorityDate |
2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |